|Articles|July 7, 2004
Miravant PDT laser receives expedited review status
The FDA accepted for filing and granted Expedited Review status to Miravant Medical Technologies' premarket application (PMA) for the IRIS Medical OcuLight 664 ophthalmic PDT laser.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
























